APA (7th ed.) Citation

Péron, J., Giai, J., Maucort-Boulch, D., & Buyse, M. (2019). The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma. Pancreas, 48(2), 275. https://doi.org/10.1097/MPA.0000000000001234

Chicago Style (17th ed.) Citation

Péron, Julien, Joris Giai, Delphine Maucort-Boulch, and Marc Buyse. "The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma." Pancreas 48, no. 2 (2019): 275. https://doi.org/10.1097/MPA.0000000000001234.

MLA (9th ed.) Citation

Péron, Julien, et al. "The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma." Pancreas, vol. 48, no. 2, 2019, p. 275, https://doi.org/10.1097/MPA.0000000000001234.